Date Filed | Type | Description |
02/24/2023 |
4
| SAENGER BRADLEY (CFO) has filed a Form 4 on Tonix Pharmaceuticals Holding Corp.
Txns:
| Granted 200,000 options
@ $0.731, valued at
$146.2k
Granted 200,000 options
@ $0.914, valued at
$182.8k
|
|
02/17/2022 |
4
| SAENGER BRADLEY (CFO) has filed a Form 4 on Tonix Pharmaceuticals Holding Corp.
Txns:
| Granted 900,000 options
@ $0.207, valued at
$186.3k
Granted 900,000 options
@ $0.414, valued at
$372.6k
Granted 900,000 options
@ $0.621, valued at
$558.9k
Granted 900,000 options
@ $0.828, valued at
$745.2k
|
|
02/11/2022 |
5
| SAENGER BRADLEY (CFO) has filed a Form 5 on Tonix Pharmaceuticals Holding Corp. |
02/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/12/2021 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
05/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/27/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/14/2020 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
05/08/2019 |
4
| SAENGER BRADLEY (CFO) has filed a Form 4 on Tonix Pharmaceuticals Holding Corp.
Txns:
| Granted 28,835 options
@ $2.05, valued at
$59.1k
Granted 28,835 options
@ $2.56, valued at
$73.8k
|
|
02/27/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/14/2018 |
4
| SAENGER BRADLEY (CFO) has filed a Form 4 on Tonix Pharmaceuticals Holding Corp.
Txns:
| Bought 300 shares
@ $4.1, valued at
$1.2k
|
|
02/15/2018 |
4
| SAENGER BRADLEY (CFO) has filed a Form 4 on Tonix Pharmaceuticals Holding Corp.
Txns:
| Granted 39,150 options
@ $3.4, valued at
$133.1k
Granted 39,150 options
@ $4.25, valued at
$166.4k
|
|
03/01/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
02/13/2017 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities |
06/21/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/31/2016 |
4
| SAENGER BRADLEY (CFO) has filed a Form 4 on Tonix Pharmaceuticals Holding Corp.
Txns:
| Granted 20,000 options
@ $2.42, valued at
$48.4k
Granted 60,000 options
@ $2.42, valued at
$145.2k
|
|
02/29/2016 |
3
| SAENGER BRADLEY (CFO) has filed a Form 3 on Tonix Pharmaceuticals Holding Corp. |